I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 30 studies | 32% ± 11% | |
| memory B cell | 18 studies | 30% ± 10% | |
| naive B cell | 18 studies | 31% ± 7% | |
| ciliated cell | 9 studies | 30% ± 12% | |
| plasma cell | 8 studies | 28% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 5% | |
| endothelial cell | 5 studies | 22% ± 6% | |
| precursor B cell | 4 studies | 29% ± 3% | |
| immature B cell | 4 studies | 29% ± 2% | |
| neuron | 4 studies | 28% ± 13% | |
| hematopoietic stem cell | 4 studies | 20% ± 4% | |
| classical monocyte | 3 studies | 25% ± 7% | |
| plasmablast | 3 studies | 35% ± 11% | |
| natural killer cell | 3 studies | 21% ± 7% | |
| platelet | 3 studies | 20% ± 5% | |
| innate lymphoid cell | 3 studies | 17% ± 1% | |
| glutamatergic neuron | 3 studies | 42% ± 15% | |
| abnormal cell | 3 studies | 26% ± 3% | |
| neutrophil | 3 studies | 17% ± 2% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% |
